Lamprene and Sputum discolored - a phase IV clinical study of FDA data

Summary:

Sputum discolored is reported as a side effect among people who take Lamprene (clofazimine), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Azithromycin, and have Atypical mycobacterial infection.

The phase IV clinical study analyzes which people have Sputum discolored when taking Lamprene. It is created by eHealthMe based on reports of 958 people who have side effects when taking Lamprene from the FDA, and is updated regularly.

What is Lamprene?

Lamprene has active ingredients of clofazimine. eHealthMe is studying from 967 Lamprene users. Check the latest studies of Lamprene.

What is Sputum discolored?

Sputum discolored is found to be associated with 915 drugs and 552 conditions by eHealthMe. Check the latest studies of Sputum discolored.

On Jul, 08, 2026

958 people reported to have side effects when taking Lamprene.
Among them, 12 people (1.25%) have Sputum discolored.

Among these 12 people:

How long have people been on Lamprene when they have Sputum discolored? *

What is the gender of people who have Sputum discolored when taking Lamprene? *

female: 33.33 %
male: 66.67 %

What is the age of people who have Sputum discolored when taking Lamprene? *

What are other drugs people take besides Lamprene? *

Azithromycin: 6 people, 50.00%
Ofev: 4 people, 33.33%
Amikacin Sulfate: 2 people, 16.67%
Rifampin: 2 people, 16.67%
Zofran: 1 person, 8.33%
Desyrel: 1 person, 8.33%
Insulin: 1 person, 8.33%
Humalog: 1 person, 8.33%
Ethambutol Hydrochloride: 1 person, 8.33%
Emla: 1 person, 8.33%

What are other side effects people have besides Sputum discolored? *

Cough: 11 people, 91.67%
Dyspnea (difficult or laboured breathing): 10 people, 83.33%
Nausea (feeling of having an urge to vomit): 8 people, 66.67%
Productive Cough: 8 people, 66.67%
Fatigue (feeling of tiredness): 8 people, 66.67%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 7 people, 58.33%
Abdominal Pain: 6 people, 50.00%
Taste - Impaired: 5 people, 41.67%
Weight Decreased: 4 people, 33.33%
Diarrhea: 4 people, 33.33%

What are the existing conditions these people have? *

Atypical Mycobacterial Infection (infections caused by several types of mycobacterium similar to the germ that causes tuberculosis): 6 people, 50.00%
Mycobacterium Avium Complex Infection: 4 people, 33.33%
Mycobacterium Abscessus Infection (rapid growing bacterial infection): 3 people, 25.00%
Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 1 person, 8.33%
Pneumonia: 1 person, 8.33%
Lower Respiratory Tract Infection: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Lamprene and have Sputum discolored?

- Check whether Sputum discolored is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lamprene:

Lamprene (967 reports)

Browse all side effects of Lamprene:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Sputum discolored:

Sputum discolored (915 drugs)

Browse all the conditions that are associated with Sputum discolored:

Sputum discolored (552 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on clofazimine (the active ingredients of Lamprene) and Lamprene (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.